Safety Recall: Nitto Pharmaceutical Industries Shin Calcitube D3 – Japan CAA

Published by Reclia Safety Desk | July 09, 2026

Recall Information Record

Case Number: 00000035511
Product: Shin Calcitube D3
Brand: Nitto Pharmaceutical Industries
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)

WHAT HAPPENED

Nitto Pharmaceutical Industries has issued a voluntary recall for its product “Shin Calcitube D3” (新カルシチュウD3), a vitamin D3 supplement. The recall was triggered by a confirmed issue where the active ingredient, cholecalciferol (vitamin D3), may fall below the approved specification limits during the product’s shelf life. This deficiency could reduce the intended efficacy of the supplement for consumers relying on it for vitamin D intake.

This matter is significant because consistent potency of active ingredients is critical for ensuring that consumers receive the expected health benefits. Sub-potent vitamin D3 supplements may not adequately support bone health, immune function, or other physiological processes, particularly for individuals with specific deficiencies or medical needs. The recall underscores the importance of rigorous quality control in pharmaceutical manufacturing to maintain consumer safety and product reliability.

If you have purchased Shin Calcitube D3, please take the following steps:

• Check the product packaging for the brand name “新カルシチュウD3” and verify if it is part of this recall.
• Discontinue use immediately and contact Nitto Pharmaceutical Industries or the point of purchase for instructions on return or replacement.
• For further details, refer to the official recall notice on the Consumer Affairs Agency website using management number 00000035511 or consult the referenced sources: PMDA, Alinamin Pharmaceutical Co., Ltd., and Nitto Pharmaceutical Industries Co., Ltd.

AFFECTED BATCHES & TARGET SPECIFICS

– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A

ADDITIONAL REGULATORY NOTES

The recall was initiated because the active ingredient cholecalciferol (vitamin D3) content may fall below approved specifications within the product’s shelf life. The recall start date is July 6, 2026. Reference information includes PMDA, Alinamin Pharmaceutical Co., Ltd., and Nitto Pharmaceutical Industries Co., Ltd. Management number: 00000035511.

❓ Frequently Asked Questions